CSST "La Rose des Vents"
Saint-Nazaire, 44600, France
NCT Number: NCT02245685
This study is part of the french priorities of the 2007-2011 addiction plan. Priority #2 of the plan underlines the need to improve practices and access to opioid substitution treatment. Priority 3 stresses the importance of articulation and coordination between specialized structures and community medicine to optimize the quality of care and to ensure continuity in the followup of these patients. This study focuses on the followup of patients under substitution therapy from the moment they enter a specialized care center for addicts to the period they are monitored by a general practitioner outside the specialized care center. The assessment described in this study should allow to harmonize and keep a continuity in patient monitoring.
Looking for future studies?
Notify MeAll sexes
Observational
Saint-Nazaire, 44600, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Time frame: From the time patients start to be followed in the specialized care center to the time they leave the specialized care center (up to 5 years)
Time frame: From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)
Time frame: From the time patients leave the specialized care center to the time they are followed by a general practitioner (up to 5 years)
Nantes University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05163171
Addiction, Behavior
Clermont-Ferrand, France
View Trial DetailsNCT07737808
Addiction, Behavior
Istanbul, bakırköy, Turkey (Türkiye)
View Trial DetailsNCT02334956
Addiction, Behavior
Bordeaux, France
View Trial DetailsNCT07590154
Addiction, Behavior
Ajijic, Jalisco, Mexico
View Trial Details